TYDE News and Press, Cryptyde Inc. From 08/19/22

Cryptyde press release ( NASDAQ: TYDE ): Q2 GAAP EPS of -$0.15. Revenue of $7.35M (+267.5% Y/Y). For further details see: Cryptyde GAAP EPS of -$0.15, revenue of $7.35M

SAFETY HARBOR, Florida, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Cryptyde, Inc., or the Company, (NASDAQ: TYDE) a company offering comprehensive, scalable Web3 services utilizing blockchain technologies, NFTs, Smart Contracts, Metaverse and Crypto, announced financial results for the three and six...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Robert Way / Shutterstock.com Li Auto (NASDAQ: LI ) stock is on the move Monday after the electric vehicle (EV) company released a disappointing earnings report for the second quarter of 2022. Starti...

Turquoise Hill Resources ( TRQ ) -18% after Turquoise Hill rejects Rio Tinto's bid to take control of huge Mongolia mine . Arcadia Biosciences ( RKDA ) -18% to raise $5M in securities offering . Root ( ROOT ) -17% . TREASURE GLOBAL ( TGL ...

If there was a week to talk about the importance of sympathy sentiment, this is the week. There have been countless breakouts from penny stocks simply because other companies are experiencing massive buying. We saw it with HKD stock, AMTD stock, LTRPB, APDN; the list is ever-growing. Today ...

AMTD IDEA ( AMTD ) +323% . 36Kr Holdings ( KRKR ) +70% . Quoin Pharmaceuticals ( QNRX ) +54% . Intelligent Living ( ILAG ) +40% . Getty Images Holdings ( GETY ) +24% stock rallies for second day, shares gain 19%. Innoviz ...

SAFETY HARBOR, Florida, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Cryptyde, Inc., or the Company, (NASDAQ: TYDE) a company offering comprehensive, scalable Web3 services utilizing blockchain technologies, announced today the recent signing of an Energy Program Development Agreement with Argo Energy...

Avaya Holdings ( AVYA ) -23% on disappointing Q3 prelim results. Roku ( ROKU ) -21% as analysts rush to downgrade following Q2 miss, weak guidance. DexCom ( DXCM ) -13% on Q2 results. Intel ( INTC ) -12% on Q2 results. Cr...

Better Therapeutics ( BTTX ) +66% Completes Pivotal Trial of BT-001 for Type 2 Diabetes and Announces Positive Secondary Endpoint Results Following the Earlier Announcement of Positive Primary Endpoint Results. JAKKS Pacific ( JAKK ) +35% CEO Stephen Berman on Q2...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com It’s time for another dive into the biggest pre-market stock movers as we check out what’s happening Thursday morning! There’s loads of earnings reports to go o...